Anzeige
Mehr »
Login
Samstag, 01.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spektakuläre Kursgewinne im neuen Rohstoff-Bullenmarkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema MIRA PHARMACEUTICALS INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiMIRA PHARMACEUTICALS, INC. - 8-K, Current Report1
20.05.MIRA Pharmaceuticals, Inc.: Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog51MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that it has advanced new preclinical studies...
► Artikel lesen
13.05.MIRA PHARMACEUTICALS, INC. - 10-Q, Quarterly Report1
02.04.MIRA Pharmaceuticals, Inc.: Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission60Ketamir-2 is a potential treatment for certain major mental health disorders impacting millions of people in the U.S. MIAMI, April 2, 2024 /PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA)...
► Artikel lesen
01.04.MIRA PHARMACEUTICALS, INC. - 10-K, Annual Report-
07.03.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report4
05.02.MIRA Pharmaceuticals, Inc.: MIRA Pharmaceuticals Provides Corporate Update207Announces Research Collaboration with Pharmaseed to Conduct Pre-Clinical Studies on the Use of Ketamir for Patients with Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD) Studies...
► Artikel lesen
17.01.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report1
18.12.23MIRA PHARMACEUTICALS, INC. - S-1, General form for registration of securities1